|Mitsubishi Chemical Holdings Corporation -- USA Stock|| |
USD 9.64 0.46 5.01%
Chief Compliance Officer, Sr. Managing Executive Officer and Representative Corporate Executive Officer
Mr. Noriyoshi Ohira was serving as Executive Vice President, Representative Executive Officer and Director in Mitsubishi Chemical Holdings Corporationrationration since June 2017. He is also serving as Director in a subsidiary, Life Science Institute, Inc. He used to work for another subsidiary, Mitsubishi Chemical Corporationrationration.
Age: 63 Executive Since 2017
81 3 6748 7200 http://www.mitsubishichem-hd.co.jp
The company has return on total asset (ROA)
of 4.88 %
which means that it generated profit of $4.88 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 14.47 %
meaning that it generated $14.47 on every $100 dollars invested by stockholders.
The company has accumulated 15.4 B in total debt with debt to equity ratio (D/E) of 85.3 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Mitsubishi Chemical Holdings Corporation has Current Ratio of 1.36 which is within standard range for the sector.
Mitsubishi Chemical Holdings Corporation engages in the performance products, industrial materials, and health care businesses in Japan and internationally. The company was founded in 2005 and is headquartered in Tokyo, Japan. Mitsubishi Chemical is traded on OTC Market in USA.Mitsubishi Chemical Holdings Corporation (MTLHF) is traded on OTC Market in USA. It is located in 1-1 Marunouchi 1-chome and employs 69,291 people.